Cystic fibrosis: the role of the small airways

Area of Science:

• Pulmonary Medicine
• Pediatric Pulmonology
• Respiratory Pathophysiology

Background:

• Cystic fibrosis (CF) infants are born with normal airway anatomy, with early histological changes noted in smaller airways.
• The small airways are hypothesized as the primary site of initial pathology in CF lung disease.
• Defining "small airways" and accurately measuring abnormalities in this region remain significant challenges.

Purpose of the Study:

• To review the current understanding of small airway involvement in cystic fibrosis pathogenesis.
• To describe diagnostic tools for assessing small airway disease in CF.
• To highlight opportunities and challenges in aerosol therapy targeting small airways in CF patients.

Main Methods:

• Literature review summarizing current research on small airway disease in cystic fibrosis.
• Analysis of diagnostic modalities for small airway abnormalities.
• Discussion of therapeutic strategies, particularly aerosol delivery to small airways.

Main Results:

• Small airway pathology is increasingly recognized as a critical component of early cystic fibrosis lung disease.
• Current dynamic lung function tests are often inadequate for detecting small airway dysfunction due to their large surface area and uneven disease distribution.
• A range of diagnostic tools exist, but none perfectly capture the extent of small airway disease in CF.

Conclusions:

• Small airways play a crucial role in the early development of cystic fibrosis lung disease.
• Improved diagnostic methods are needed to accurately assess and monitor small airway abnormalities.
• Targeting small airways with aerosol therapy presents potential benefits but also significant delivery challenges in CF patients.